Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins.

We have previously demonstrated that astrocytes synthesize and secrete apolipoprotein E in situ. In the present work, primary cultures of rat brain astrocytes were used to study apolipoprotein E synthesis, secretion, and metabolism in vitro. The astrocytes in culture contained immunoreactive apolipoprotein E in the area of the Golgi apparatus. Incubation of the astrocytes with [35S]methionine resulted in the secretion of labeled immunoprecipitable apolipoprotein E, which constituted 1-3% of the total secreted proteins. The apolipoprotein E secreted in culture and the apolipoprotein E in rat brain extracts differed from serum apolipoprotein E in two respects: both had a slightly higher apparent molecular weight (approx. 36,000) and more acidic isoforms than serum apolipoprotein E. Sialylation of the newly secreted apolipoprotein accounted for the difference in both the apparent molecular weight and isoelectric focusing pattern of newly secreted apolipoprotein E and plasma apolipoprotein E. The astrocytes possessed apolipoprotein B,E(LDL) receptors capable of binding and internalizing apolipoprotein E-containing lipoproteins. The uptake of lipoproteins by the cells led to a reduction in the number of cell surface receptors and to the intracellular accumulation of cholesteryl esters. Since apolipoprotein E is present within the brain, and since brain cells can express apolipoprotein B,E(LDL) receptors, apolipoprotein E-containing lipoproteins may function to redistribute lipid and regulate cholesterol homeostasis within the brain.

[1]  R. Mahley,et al.  Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. , 1982, Journal of lipid research.

[2]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[3]  R. Mahley,et al.  Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein. , 1980, The Journal of biological chemistry.

[4]  M. Brown,et al.  Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. , 1982, The Journal of biological chemistry.

[5]  E. Shooter,et al.  Expression of specific sheath cell proteins during peripheral nerve growth and regeneration in mammals , 1986, The Journal of cell biology.

[6]  R. Mahley.  Development of accelerated atherosclerosis. Concepts derived from cell biology and animal model studies. , 1983, Archives of pathology & laboratory medicine.

[7]  J. Fox,et al.  Organization of the cytoskeleton in resting, discoid platelets: preservation of actin filaments by a modified fixation that prevents osmium damage , 1985, The Journal of cell biology.

[8]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[9]  R. Mahley.  Atherogenic hyperlipoproteinemia. The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. , 1982, The Medical clinics of North America.

[10]  M. Brown,et al.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[11]  R. Mahley,et al.  Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. , 1985, Journal of Biological Chemistry.

[12]  N. Baumann,et al.  Distribution of radioactivity in myelin lipids following subcutaneous injection of [14C]stearate. , 1978, Biochimica et biophysica acta.

[13]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[14]  M. Brown,et al.  Regulation of plasma cholesterol by lipoprotein receptors. , 1981, Science.

[15]  M. Brown,et al.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.

[16]  M. Brown,et al.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. , 1983, Methods in enzymology.

[17]  R. Mahley,et al.  Lipoprotein-receptor interactions. , 1986, Methods in enzymology.

[18]  R J Havel,et al.  Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. , 1982, Journal of lipid research.

[19]  R. Mahley,et al.  Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. , 1978, Biochemistry.

[20]  V. P. Collins,et al.  Delivery of aclacinomycin A to human glioma cells in vitro by the low-density lipoprotein pathway. , 1983, Cancer research.

[21]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[22]  E. Shooter,et al.  A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. , 1985, Science.

[23]  D. L. Fry,et al.  Canine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro. , 1977, The American journal of pathology.

[24]  R. Mahley,et al.  A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1. , 1984, The Journal of clinical investigation.

[25]  R. Mahley,et al.  Disparities in the interaction of rat and human lipoproteins with cultured rat fibroblasts and smooth muscle cells. Requirements for homology for receptor binding activity. , 1980, The Journal of biological chemistry.

[26]  J. Breslow,et al.  Characterization of the major apolipoproteins secreted by two human hepatoma cell lines. , 1981, Biochemistry.

[27]  R. Mahley,et al.  Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. , 1979, The Journal of clinical investigation.

[28]  R. Mahley,et al.  Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro. , 1983, The Journal of biological chemistry.

[29]  R. Mahley,et al.  Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins. , 1980, The Journal of biological chemistry.

[30]  R. Mahley,et al.  Lipoprotein receptors and cholesterol homeostasis. , 1983, Biochimica et biophysica acta.

[31]  J. Volpe,et al.  Regulation of cholesterol ester synthesis in cultured glial and neuronal cells. Relation to control of cholesterol synthesis. , 1978, Biochimica et biophysica acta.

[32]  W. Hunter,et al.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.

[33]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[34]  J. Weinstein,et al.  Acetoacetylated Lipoproteins Used to Distinguish Fibroblasts from Macrophages In Vitro by Fluorescence Microscopy , 1981, Arteriosclerosis.

[35]  J. Taylor,et al.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.

[36]  R. Mahley,et al.  Apolipoprotein E Is the Determinant that Mediates the Receptor Uptake of B‐Very Low Density Lipoproteins by Mouse Macrophages , 1986, Arteriosclerosis.

[37]  D. Illingworth,et al.  THE COMPOSITION OF LIPIDS IN CEREBROSPINAL FLUID OF CHILDREN AND ADULTS , 1971, Journal of Neurochemistry.

[38]  R. Mahley,et al.  Foam Cells in Explants of Atherosclerotic Rabbit Aortas Have Receptors for β‐Very Low Density Low Density Lipoproteins and Modified Low Density Lipoproteins , 1983, Arteriosclerosis.